10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -112,485 | -18,762 | N/A |
| Depreciation Amortization | 3,905 | 4,305 | N/A |
| Accounts receivable | -14,747 | -5,131 | N/A |
| Accounts payable and accrued liabilities | 2,587 | 3,034 | N/A |
| Other Working Capital | 28,015 | 1,948 | N/A |
| Other Operating Activity | 16,316 | 3,907 | 0 |
| Operating Cash Flow | $-76,409 | $-10,699 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -6,284 | -3,756 | N/A |
| Purchase Sale Intangibles | -425 | N/A | N/A |
| Other Investing Activity | -425 | 0 | 0 |
| Investing Cash Flow | $-6,709 | $-3,756 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 19,512 | N/A | N/A |
| Debt Repayment | -773 | -393 | N/A |
| Common Stock Issued | 1,798 | 1,092 | N/A |
| Common Stock Repurchased | N/A | -80 | N/A |
| Other Financing Activity | 84,830 | 19,964 | 0 |
| Financing Cash Flow | $105,367 | $20,583 | $N/A |
| Exchange Rate Effect | -18 | -14 | N/A |
| Beginning Cash Position | 47,857 | 41,743 | N/A |
| End Cash Position | 70,088 | 47,857 | N/A |
| Net Cash Flow | $22,231 | $6,114 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -76,409 | -10,699 | N/A |
| Capital Expenditure | -6,284 | -3,756 | N/A |
| Free Cash Flow | -82,693 | -14,455 | 0 |